Live feed07:05:00·1911dPRReleasevia QuantisnowIonis reports positive topline Phase 2 study results of its novel antisense treatment for hereditary angioedemaByQuantisnow·Wall Street's wire, on your screen.IONS· Ionis Pharmaceuticals Inc.Health CareOriginal source
